Cargando…
A nonrandomized controlled study of sacral giant cell tumors with preoperative treatment of denosumab
The aim of this nonrandomized controlled study (level 3)was to evaluate whether preoperative denosumab treatment can reduce intraoperative blood loss, facilitate surgical treatment, and improve local control of sacral giant-cell tumor (GCT). Surgical treatment of sacral GCT is very difficult due to...
Autores principales: | Yang, Yongkun, Li, Yuan, Liu, Weifeng, Xu, Hairong, Niu, Xiaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257612/ https://www.ncbi.nlm.nih.gov/pubmed/30431583 http://dx.doi.org/10.1097/MD.0000000000013139 |
Ejemplares similares
-
Study of imaging changes following preoperative denosumab for giant cell tumor of bone
por: Yang, Yongkun, et al.
Publicado: (2021) -
The clinical outcome of recurrent sacral chordoma with further surgical treatment
por: Yang, Yongkun, et al.
Publicado: (2018) -
Clinical characteristics and risk factors analysis of lung metastasis from benign giant cell tumor of bone()
por: Yang, Yongkun, et al.
Publicado: (2017) -
A Retrospective Observational Study on Disease Characteristics and Treatment Patterns of Giant Cell Tumor of the Bone in China
por: Xu, Hairong, et al.
Publicado: (2023) -
Giant cell tumour of the bone treated with denosumab: How has the blood supply and oncological prognosis of the tumour changed?
por: Niu, Xiaohui, et al.
Publicado: (2018)